Phoenix Biotech Acquisiti... (PBAX)
NASDAQ: PBAX
· Real-Time Price · USD
5.85
0.37 (6.75%)
At close: Feb 14, 2024, 9:56 PM
Phoenix Biotech Acquisition Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Net Income | -14.25M | -9.48M | -5.88M | -2.52M | -2.1M | -771.45K | -667.74K | -719.61K | -805.11K | -693.54K | -315.55K | -1K |
Depreciation & Amortization | 2.22M | 1.95M | 832.45K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 480.76K | 175.81K | 78.92K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 1.54M | 1.58M | 398.38K | -243.18K | -102.05K | 419.82K | 773.67K | -116.08K | -291.52K | -389.74K | -379.51K | n/a |
Other Non-Cash Items | 1.21M | 1.09M | 270.84K | -1.94M | -2.8M | -2.92M | -2.84M | -1.29M | -308.27K | -43.26K | -16.48K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.39M | -2.2M | -193.06K | 2.75M | 3.27M | 2.71M | 2.41M | 593.28K | -128.52K | -268.39K | -365.08K | 1K |
Operating Cash Flow | -12.65M | -8.46M | -4.89M | -1.71M | -1.63M | -981.93K | -1.09M | -1.42M | -1.24M | -1.01M | -697.11K | n/a |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 443.85K | 443.85K | -275K | -700K | -700K | -425K | -325K | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | -5.64M | -560.24K | 5.64M | 5.64M | 560.24K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -864.22K | 4.82M | 5.5M | 186.72M | 181.04M | 181.04M | 181.04M | 0.13 | n/a | n/a | n/a | n/a |
Investing Cash Flow | -6.06M | -370.47K | 5.79M | 186.58M | 180.9M | 180.61M | 180.71M | -178.5M | -178.5M | -178.5M | -178.5M | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 5.64M | n/a | -5.64M | -144.99M | -139.35M | -139.35M | -139.35M | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 6.75M | -4.28M | -4.32M | -143.6M | -138.18M | -138.7M | -138.7M | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 12.36M | 618.36K | -4.32M | -4.89M | 524.86K | -138.7 | -138.7 | n/a | n/a | n/a | n/a | n/a |
Net Cash Flow | 5.82M | 3.95M | 2.4M | 41.28M | 41.22M | 41.05M | 41.04M | -179.79M | -179.74M | -179.51M | -179.2M | n/a |
Free Cash Flow | -12.65M | -8.46M | -4.89M | -1.71M | -1.63M | -981.93K | -1.09M | -1.42M | -1.24M | -1.01M | -697.11K | n/a |